A little while ago we reported
that there was encouraging research carried out to see whether medications
containing GLP-1 would be useful in treating obesity. In light of this, we are
not surprised to hear about the promising results of a large-scale study.
The phase III trial, which was
completed in Denmark, included a total of 846 overweight or obese individuals.
The participants were randomly split into three groups who were then treated
with 3mg Liraglutide, 1.8 mg Liraglutide or a placebo. The participants were
further observed for 12 weeks after the cessation of the programme. The key
findings indicated that individuals who received the highest dosage of Liraglutide
also had the highest weight-loss. Specifically, 50% of the individuals in the 3
mg group lost at least 5% of their body weight, and 22% lost 10% of their
weight during the course of the treatment. Similarly, 35% of individuals in the
group that received 1.8mg of Liraglutide lost 5% of their body weight and 13%
of the participants in this group lost 10% of their weight. In contrast to
this, only 13% of the individuals in the placebo group lost 5% of their weight
and 4% lost 10% of their weight. However, across groups it was clear that
participants were not able to maintain their complete weight loss once they had
stopped their treatment. The combination of these findings led the researchers
to suggest that there is potential for Liraglutide to be a useful treatment for
weight loss.
The findings from this study are
certainly encouraging especially as it was carried out for such a long period
of time with low attrition rates of a rather large sample. Moreover, the fact
that it was a double blind study and that so many of the results reached
statistical significance reflected that there are good reasons to further
research this area. However, it also raised important clinical questions that
need to be addressed, with dosage and length of treatment appearing as the most
obvious ones.
The Online Clinic can prescribe
Victoza (Liraglutide) as a weight loss treatment if it is appropriate for you.
Some patients have had extremely good results with this product.
Free Online AssessmentQuick and Without Obligation